STOCK TITAN

Semler Scientific Inc SEC Filings

SMLR NASDAQ

Welcome to our dedicated page for Semler Scientific SEC filings (Ticker: SMLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

QuantaFlo® device sales on one page, fair-value bitcoin gains on the next—Semler Scientific’s disclosures can feel like two different companies inside a single filing. Whether you are combing through a Semler Scientific quarterly earnings report 10-Q filing for unit volumes or hunting the note that explains recent crypto purchases, deciphering hundreds of pages is tough. This page delivers Semler Scientific SEC filings explained simply so you can stop scrolling and start understanding.

Stock Titan’s AI reads every submission the moment it hits EDGAR and turns it into plain-English answers. Need the footnote that reconciles BTC holdings? Our engine flags it. Curious about board incentives? The Semler Scientific proxy statement executive compensation section is highlighted automatically. Real-time alerts cover Semler Scientific Form 4 insider transactions real-time and summarize each trade, while one-click views join every Semler Scientific 8-K material events explained with context. Here’s what you’ll find:

  • Semler Scientific annual report 10-K simplified—AI extracts QuantaFlo revenue, R&D spend and bitcoin valuation swings.
  • Instant dashboards for Semler Scientific insider trading Form 4 transactions and executive buying patterns.
  • Concise tables that power Semler Scientific earnings report filing analysis across sequential quarters.
  • Full text search, tagging and export for auditing or modelling.

Professionals use these insights to monitor reimbursement risk, gauge PAD market penetration, or track digital-asset strategy without reading each footnote. Whether you’re understanding Semler Scientific SEC documents with AI, reviewing Semler Scientific executive stock transactions Form 4, or studying supply-chain commentary, Stock Titan keeps you ahead of the next disclosure—no manual parsing required.

Rhea-AI Summary

Semler Scientific, Inc. (SMLR) – Form 4 Overview

Director Natalie Brunell reported the grant of a single derivative security on 25 June 2025. The filing covers a stock option to purchase 1,125 shares of common stock at an exercise price of $41.04 per share. The instrument is classified as an acquisition (transaction code “A”).

Vesting schedule: 1/6 of the option (≈188 shares) vested immediately on the grant date, with the remaining 5/6 vesting in equal monthly tranches, resulting in full vesting six months after 25 June 2025. The option expires on 25 June 2035.

Post-transaction holdings: Ms. Brunell now beneficially owns 1,125 derivative securities directly. No non-derivative (outright share) transactions were reported.

No 10b5-1 trading plan was indicated, and no other insider participated in this filing. The grant appears to be a routine director compensation award and does not include any immediately exercisable common-stock sales or purchases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
current report
-
Rhea-AI Summary

Semler Scientific (Nasdaq:SMLR) filed a Form 8-K to report that on June 22, 2025 its board adopted Fifth Amended and Restated Bylaws, effective immediately.

According to Item 5.03, the revisions are limited to two governance housekeeping items: (i) removal of Section 13 to eliminate any ambiguity with Delaware General Corporation Law §228 (shareholder written consents) and (ii) revision of Section 47 so that the bylaws fully harmonize with the company’s certificate of incorporation. No changes were made to the fiscal year, capital structure, or shareholder voting thresholds.

The full text of the updated bylaws is provided as Exhibit 3.1. Other than the technical governance clean-up, the filing contains no financial statements, forward-looking guidance, or other material events. The document was signed by Chief Financial Officer Renae Cormier on June 23, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Semler Scientific (SMLR)?

The current stock price of Semler Scientific (SMLR) is $38.5 as of June 28, 2025.

What is the market cap of Semler Scientific (SMLR)?

The market cap of Semler Scientific (SMLR) is approximately 474.9M.

What core services does Semler Scientific provide?

Semler Scientific develops, manufactures, and markets innovative diagnostic products and testing solutions for healthcare providers to effectively manage and combat chronic diseases.

What is QuantaFlo® and how is it used?

QuantaFlo® is a rapid point-of-care test patented and cleared by the FDA. It measures arterial blood flow in the extremities to help diagnose cardiovascular conditions such as peripheral arterial disease (PAD) and assess patient risk of major adverse cardiovascular events (MACE).

How does Semler Scientific integrate bitcoin into its business model?

Beyond its healthcare diagnostics, Semler Scientific employs a disciplined treasury strategy by acquiring and holding bitcoin as its primary digital asset, using metrics like BTC Yield to gauge the performance of its digital asset investments relative to its equity.

In which industries does Semler Scientific operate?

The company operates at the intersection of healthcare technology and financial strategy, with a strong focus on medical diagnostics for chronic diseases and innovative treasury management through digital assets.

What is BTC Yield and why is it important?

BTC Yield is a key performance indicator used by Semler Scientific to measure the relative change in its bitcoin holdings against its assumed diluted shares outstanding. It helps contextualize the impact of its digital asset strategy on shareholder value.

How does Semler Scientific’s product benefit healthcare providers?

Its diagnostic solutions, particularly QuantaFlo®, provide rapid and reliable data on arterial blood flow, enabling healthcare providers to promptly diagnose cardiovascular conditions and make informed treatment decisions, thereby optimizing patient care.

What differentiates Semler Scientific from other diagnostic technology companies?

Semler Scientific stands out due to its dual focus on delivering cutting-edge, FDA-cleared diagnostic products and adopting a distinct treasury strategy that leverages bitcoin as a core asset, thereby merging clinical innovation with modern financial management.
Semler Scientific Inc

NASDAQ:SMLR

SMLR Rankings

SMLR Stock Data

474.92M
9.39M
18.39%
61.37%
17.11%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
CAMPBELL